Dr. Jianmin Fang

Scientific Committee Chair

Ph.D. Dalhousie University in Canada and Post-Doctor fellow at Harvard Medical School

>20 years experience in biopharma R&D, including >10 years in the U.S.

Co-founder of Remegen. Startup experience in Silicon Valley

Numerous publications in top academic journals and >40 drug invention patents

Inventor of combercept

Member of Scientific Advisory Board for China’s National Major Drug Innovation Program administrated by the Ministry of Science and Technology and Ministry of Health of China                

Dr. Daotian Fu

Scientific Committee member

Ph.D. Iowa State University and Post-Doctorate fellow at University of Georgia complex sugar research center and Harvard Medical School

>20 years U.S. pharma R&D experience

Extensive experience in clinical and listing applications in the United States and internationally

Vice President and Executive Director of Livzon Pharmaceutical Group, Director of Epirus Biopharma from 2012 to 2018                

Dr. Ruyi He

Scientific Committee member

Medical degree from China Medical University; completed his intern and residency training in Internal Medicine at Howard University Hospital

Practice as a physician in USA

Officer in the CDER, U.S. FDA from 1999 to 2016

Chief Scientist at the Center for Drug Evaluation at the NMPA in China from 2016 to 2018